Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:44 UTC |
---|
HMDB ID | HMDB0014766 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Clorazepate |
---|
Description | Clorazepate is only found in individuals that have used or taken this drug. It is a water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. |
---|
Structure | OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2 InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22) |
---|
Synonyms | Value | Source |
---|
7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid | ChEBI | Clorazepate | ChEBI | 7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate | Generator | Chlorazepate | MeSH | Clorazepate dipotassium | MeSH | Clorazepate monopotassium | MeSH | Dipotassium chlorazepate | MeSH | Tranxene | MeSH | Tranxilium | MeSH | Clorazepic acid | Generator, KEGG | Dipotassium, clorazepate | MeSH, HMDB | Monopotassium, clorazepate | MeSH, HMDB | Chlorazepate, dipotassium | MeSH, HMDB |
|
---|
Chemical Formula | C16H11ClN2O3 |
---|
Average Molecular Weight | 314.723 |
---|
Monoisotopic Molecular Weight | 314.045819935 |
---|
IUPAC Name | 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid |
---|
Traditional Name | clorazepate |
---|
CAS Registry Number | 23887-31-2 |
---|
SMILES | OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2 |
---|
InChI Identifier | InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22) |
---|
InChI Key | XDDJGVMJFWAHJX-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | 1,4-benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - 1,4-benzodiazepine
- Alpha-amino acid or derivatives
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- 1,3-dicarbonyl compound
- Carboxamide group
- Ketimine
- Lactam
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Carboxylic acid
- Azacycle
- Organic 1,3-dipolar compound
- Monocarboxylic acid or derivatives
- Propargyl-type 1,3-dipolar organic compound
- Organopnictogen compound
- Organic oxygen compound
- Imine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organohalogen compound
- Organochloride
- Organonitrogen compound
- Organooxygen compound
- Carbonyl group
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.025 g/L | Not Available | LogP | 3 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Clorazepate,1TMS,isomer #1 | C[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O | 2747.3 | Semi standard non polar | 33892256 | Clorazepate,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)C(C(=O)O)N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21 | 2537.5 | Semi standard non polar | 33892256 | Clorazepate,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C)C1=O | 2549.5 | Semi standard non polar | 33892256 | Clorazepate,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C)C1=O | 2653.3 | Standard non polar | 33892256 | Clorazepate,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C)C1=O | 3608.9 | Standard polar | 33892256 | Clorazepate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O | 2947.5 | Semi standard non polar | 33892256 | Clorazepate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)C(C(=O)O)N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21 | 2837.6 | Semi standard non polar | 33892256 | Clorazepate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C(C)(C)C)C1=O | 2989.4 | Semi standard non polar | 33892256 | Clorazepate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C(C)(C)C)C1=O | 3061.2 | Standard non polar | 33892256 | Clorazepate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N([Si](C)(C)C(C)(C)C)C1=O | 3720.0 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-2090000000-36dc0db4681a42cb62d1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (1 TMS) - 70eV, Positive | splash10-00xr-9153000000-20955633c43ee4b5fcf3 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clorazepate GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 10V, Positive-QTOF | splash10-014i-0039000000-04f8ade5dbb98231f6d5 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 20V, Positive-QTOF | splash10-014i-0194000000-77f2c863a9b5ed450724 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 40V, Positive-QTOF | splash10-0w4r-3390000000-08793ab9fa2d5c97ebe8 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 10V, Negative-QTOF | splash10-03xr-0089000000-f7743c0f914c2fc65685 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 20V, Negative-QTOF | splash10-014i-1092000000-a7f9ddb60f21ad0d8c34 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 40V, Negative-QTOF | splash10-0006-9010000000-4ba3a72ff61da2cab011 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 10V, Positive-QTOF | splash10-014i-0009000000-3b6dc9550f10c7fb899e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 20V, Positive-QTOF | splash10-00kb-0095000000-26882b3fd53c73fd3908 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 40V, Positive-QTOF | splash10-03di-0090000000-4b8c3ab746b6ade0d1f6 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 10V, Negative-QTOF | splash10-03di-0009000000-4c893c51087ae5eb95c9 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 20V, Negative-QTOF | splash10-014i-2090000000-16b08349edcd85152d86 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clorazepate 40V, Negative-QTOF | splash10-001l-9000000000-071a2b32b700b46350ad | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00628 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00628 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00628 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 2707 |
---|
KEGG Compound ID | C06921 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Clorazepate |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 2809 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 3761 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Authors unspecified: Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines. Br Med J. 1980 Mar 29;280(6218):910-2. [PubMed:7388368 ]
- McElhatton PR: The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol. 1994 Nov-Dec;8(6):461-75. [PubMed:7881198 ]
|
---|